a Department of Respiratory Medicine , Baskent University , Istanbul , Turkey.
b Department of Respiratory Medicine , Baskent University , Adana , Turkey.
COPD. 2017 Aug;14(4):429-438. doi: 10.1080/15412555.2017.1336527. Epub 2017 Jun 21.
Non-invasive ventilation (NIV) has been recommended as the first-line ventilation modality for acute respiratory failure (ARF) due to acute exacerbation of chronic obstructive pulmonary disease (AECOPD) based on strong evidence. However, everyday clinical practice may differ from findings of multiple randomized controlled trials. Physicians and respiratory therapists involved in NIV management have been queried about its utilization and effectiveness. In addition to these estimates, cohort studies and analysis of large inpatient dataset of patients with AECOPD and ARF managed with NIV have been extensively published over the last two decades. This review summarizes the perception of medical staff vs. the "real life" data about NIV use for ARF in AECOPD patients.
基于强有力的证据,推荐将无创通气(NIV)作为慢性阻塞性肺疾病急性加重(AECOPD)所致急性呼吸衰竭(ARF)的一线通气方式。然而,日常临床实践可能与多项随机对照试验的结果有所不同。参与 NIV 管理的医生和呼吸治疗师已经对其使用和效果进行了评估。除了这些估计值外,过去二十年还广泛发表了关于接受 NIV 治疗的 AECOPD 和 ARF 患者的队列研究和大型住院患者数据集的分析。这篇综述总结了医务人员对 NIV 在 AECOPD 患者中治疗 ARF 的看法与“真实生活”数据之间的差异。